Smith & Nephew Snats ADR (SNN)

$30.21 +0.31 (1.04%)
Market Cap 13.10B
Revenue (ttm) 5.81B
Net Income (ttm) 412.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 15.21
Profit Margin 7.09%
Debt to Equity Ratio 0.62
Volume 853,800
Avg Vol 787,492
Day's Range N/A - N/A
Shares Out 437.97M
Stochastic %K 97%
Beta 0.68
Analysts Sell
Price Target $29.85

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization o...

Industry: Medical Devices
Sector: Healthcare
Phone: 44 1923 477 100
Address:
Building 5, Croxley Park Hatters Lane, Watford, United Kingdom
ZacksResearch
ZacksResearch Jun. 26 at 4:42 PM
$SNN just dropped a game-changer for orthopedic surgeons 🦴 They launched TRIGEN MAX — the only tibia nailing system with side-specific nails for more precise, low-impact fracture repair. Full details on this tech expansion here 👉 https://www.zacks.com/stock/news/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554882_TEASER
0 ¡ Reply
ZacksResearch
ZacksResearch Jun. 26 at 2:21 PM
$SNN launches innovative TRIGEN MAX Tibia Nailing System — could this boost its market share? 🚀 📈 Year-to-date, shares up 21.6%, outpacing the industry’s 6.6% growth. 🔧 Unique side-specific nails aim to optimize fragment fixation and minimize soft tissue irritation, strengthening SNN's position in orthopedic trauma. Discover how this could impact SNN's future performance 👉 https://www.zacks.com/commentary/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-body-192&ADID=SYND_STOCKTWITS_TWEET_2_2554882_BODY_192
0 ¡ Reply
scottgrant2
scottgrant2 Jun. 23 at 5:32 PM
$RCEL wish smith and nephew would go ahead and buy them.. $SNN
1 ¡ Reply
ZacksResearch
ZacksResearch Jun. 20 at 4:12 PM
$SNN partners with Standard Health for UK's first Orthopaedic ASC! 🏥 📈 SNN shares have gained 16.3% in the year-to-date period vs. the industry’s 3.7% 🚀 Positions SNN in the high-growth ASC market 🔧 Enhances surgical tech adoption + boosts recurring revenue See what this means for SNN's growth strategy 👉 https://www.zacks.com/commentary/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-body&ADID=SYND_STOCKTWITS_TWEET_2_2520779_BODY
0 ¡ Reply
ZacksResearch
ZacksResearch Jun. 20 at 2:43 PM
$SNN just made a strategic move that could shake up the orthopedic space 🦴 Teaming with Standard Health, it’s launching the UK’s first orthopedic ASC — a big play to boost surgical efficiency and fuel growth. See why this could be a game-changer for SNN 👉 https://www.zacks.com/stock/news/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2520779_TEASER
0 ¡ Reply
JarvisFlow
JarvisFlow May. 1 at 7:57 PM
Canaccord Genuity has adjusted their stance on Smith & Nephew ( $SNN ), setting the rating to Hold with a target price of 27 → 28.
0 ¡ Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Mar. 26 at 7:33 PM
Smith & Nephew ($SNN) finds itself in the surgical sweet spot as the global market eyes $56.6B by 2029. With robotic systems like CORI and leadership in orthopedics, they're scrubbed in for growth. Now if they can just stop burning through cash faster than a cauterizing pen... https://www.prnewswire.com/news-releases/global-surgical-equipment-market-expected-to-reach-usd-56-6-billion-by-2029--302412416.html
0 ¡ Reply
JarvisFlow
JarvisFlow Mar. 17 at 3:40 PM
Canaccord Genuity updates rating for Smith & Nephew ( $SNN ) to Hold, target set at 27.
0 ¡ Reply
JarvisFlow
JarvisFlow Mar. 12 at 2:33 PM
UBS updates rating for Smith & Nephew ( $SNN ) to Neutral.
0 ¡ Reply
JarvisFlow
JarvisFlow Feb. 26 at 5:51 PM
Canaccord Genuity updates rating for Smith & Nephew ($SNN) to Hold, target set at 27.
0 ¡ Reply
Latest News on SNN
Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures

Jun 24, 2025, 10:00 AM EDT - 2 days ago

Smith+Nephew's new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing' to trauma surgeons repairing tibial fractures

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Jun 23, 2025, 8:00 AM EDT - 3 days ago

Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

Jun 18, 2025, 4:00 AM EDT - 9 days ago

Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Jun 9, 2025, 10:00 AM EDT - 17 days ago

New medial stabilized insert for Smith+Nephew's LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

May 27, 2025, 10:00 AM EDT - 4 weeks ago

Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

May 7, 2025, 8:00 AM EDT - 7 weeks ago

Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

May 5, 2025, 2:00 AM EDT - 7 weeks ago

Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland

Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript

May 2, 2025, 5:42 PM EDT - 7 weeks ago

Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Apr 19, 2025, 10:09 PM EDT - 2 months ago

Smith & Nephew: Underappreciated Recovery With Strategic Upside

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

Apr 3, 2025, 9:34 AM EDT - 3 months ago

Trump tariffs: these two European healthcare stocks face the highest US revenue exposure

NVO

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Mar 11, 2025, 11:00 AM EDT - 3 months ago

Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Mar 10, 2025, 11:00 AM EDT - 3 months ago

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Mar 6, 2025, 10:00 AM EST - 4 months ago

New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

Mar 3, 2025, 8:20 AM EST - 4 months ago

Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Feb 25, 2025, 11:00 AM EST - 4 months ago

We are having constructive engagement with activist shareholders, says Smith & Nephew CEO

Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 10:16 AM EST - 4 months ago

Smith & Nephew plc (SNN) Q4 2024 Earnings Call Transcript

UK's Smith+Nephew beats annual profit expectations

Feb 25, 2025, 2:09 AM EST - 4 months ago

UK's Smith+Nephew beats annual profit expectations

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Feb 16, 2025, 6:00 PM EST - 4 months ago

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

Feb 3, 2025, 10:00 AM EST - 5 months ago

Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes

Smith & Nephew Getting No Credit For Self-Improvement Efforts

Jan 29, 2025, 8:37 AM EST - 5 months ago

Smith & Nephew Getting No Credit For Self-Improvement Efforts

Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention

Jan 14, 2025, 8:00 AM EST - 5 months ago

Smith+Nephew's ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable' Evidence Bar™ ratings from ECRI for pressure injury prevention

Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin

Jan 14, 2025, 4:22 AM EST - 5 months ago

Topical Scar Treatment Market to Grow from $1.71 Billion in 2024 to $5.91 Billion by 2035 - Dominated by Smith & Nephew, Molnlycke Health Care, Alliance Pharma, HRA Pharma, and Rejuvaskin

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Dec 19, 2024, 10:00 AM EST - 6 months ago

Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Dec 16, 2024, 10:00 AM EST - 6 months ago

Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty

Big investors call for break-up of Smith & Nephew, FT reports

Nov 14, 2024, 12:24 AM EST - 8 months ago

Big investors call for break-up of Smith & Nephew, FT reports

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Nov 10, 2024, 1:02 PM EST - 8 months ago

Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends

Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript

Nov 2, 2024, 8:57 AM EDT - 8 months ago

Smith & Nephew plc (SNN) Q3 2024 Earnings Conference Call Transcript

Smith & Nephew slashes annual revenue forecast on weak China

Oct 31, 2024, 3:17 AM EDT - 8 months ago

Smith & Nephew slashes annual revenue forecast on weak China

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Oct 16, 2024, 9:00 AM EDT - 9 months ago

RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

Oct 9, 2024, 8:00 AM EDT - 9 months ago

Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery

This stock is 'boring' but has 'fantastic' risk-reward: Scharf

Sep 18, 2024, 12:40 PM EDT - 10 months ago

This stock is 'boring' but has 'fantastic' risk-reward: Scharf

First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Sep 18, 2024, 10:00 AM EDT - 10 months ago

First cases using Smith+Nephew's new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Sep 10, 2024, 10:00 AM EDT - 10 months ago

Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides

Smith & Nephew Delivering On Its Turnaround Promise

Aug 21, 2024, 8:30 PM EDT - 11 months ago

Smith & Nephew Delivering On Its Turnaround Promise

Smith & Nephew plc (SNN) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 4:21 PM EDT - 11 months ago

Smith & Nephew plc (SNN) Q2 2024 Earnings Call Transcript

Smith & Nephew shares rise as profit beats market forecast

Aug 1, 2024, 3:28 AM EDT - 11 months ago

Smith & Nephew shares rise as profit beats market forecast

Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins

Jul 13, 2024, 9:20 AM EDT - 1 year ago

Activist Cevian has a stake in medical device company Smith & Nephew. How it may help improve margins

Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge

Jul 5, 2024, 9:35 AM EDT - 1 year ago

Activist Investor Takes Stake In Sports Medicine Player Smith & Nephew, Shares Surge

Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake

Jul 4, 2024, 9:59 AM EDT - 1 year ago

Smith & Nephew shares surge as activist Cevian Capital reveals 5% stake

U.K. Top 40 Quality Dividend Stocks: Summer 2024

Jul 3, 2024, 1:25 PM EDT - 1 year ago

U.K. Top 40 Quality Dividend Stocks: Summer 2024

AZN BTI DEO NGG POLA RELX UL

Smith & Nephew: Work To Be Done But Still Long-Term Potential

Jun 11, 2024, 8:38 PM EDT - 1 year ago

Smith & Nephew: Work To Be Done But Still Long-Term Potential

Smith & Nephew plc (SNN) Q1 2024 Sales/Trading Statement Call Transcript

May 1, 2024, 3:14 PM EDT - 1 year ago

Smith & Nephew plc (SNN) Q1 2024 Sales/Trading Statement Call Transcript

U.K. Top 40 Quality Dividend Stocks: Q2 2024

Apr 12, 2024, 1:30 PM EDT - 1 year ago

U.K. Top 40 Quality Dividend Stocks: Q2 2024

AZN BTI DEO NGG RELX UL

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Apr 8, 2024, 6:00 PM EDT - 1 year ago

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Apr 4, 2024, 11:13 AM EDT - 1 year ago

Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Mar 25, 2024, 8:00 AM EDT - 1 year ago

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 1:13 AM EST - 1 year ago

Smith & Nephew plc (SNN) Q4 2023 Earnings Call Transcript

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Feb 13, 2024, 8:00 AM EST - 1 year ago

Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

Feb 12, 2024, 3:00 PM EST - 1 year ago

Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting

ZacksResearch
ZacksResearch Jun. 26 at 4:42 PM
$SNN just dropped a game-changer for orthopedic surgeons 🦴 They launched TRIGEN MAX — the only tibia nailing system with side-specific nails for more precise, low-impact fracture repair. Full details on this tech expansion here 👉 https://www.zacks.com/stock/news/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554882_TEASER
0 ¡ Reply
ZacksResearch
ZacksResearch Jun. 26 at 2:21 PM
$SNN launches innovative TRIGEN MAX Tibia Nailing System — could this boost its market share? 🚀 📈 Year-to-date, shares up 21.6%, outpacing the industry’s 6.6% growth. 🔧 Unique side-specific nails aim to optimize fragment fixation and minimize soft tissue irritation, strengthening SNN's position in orthopedic trauma. Discover how this could impact SNN's future performance 👉 https://www.zacks.com/commentary/2554882/snn-expands-orthopedic-portfolio-with-advanced-tibia-nailing-system?cid=sm-stocktwits-2-2554882-body-192&ADID=SYND_STOCKTWITS_TWEET_2_2554882_BODY_192
0 ¡ Reply
scottgrant2
scottgrant2 Jun. 23 at 5:32 PM
$RCEL wish smith and nephew would go ahead and buy them.. $SNN
1 ¡ Reply
ZacksResearch
ZacksResearch Jun. 20 at 4:12 PM
$SNN partners with Standard Health for UK's first Orthopaedic ASC! 🏥 📈 SNN shares have gained 16.3% in the year-to-date period vs. the industry’s 3.7% 🚀 Positions SNN in the high-growth ASC market 🔧 Enhances surgical tech adoption + boosts recurring revenue See what this means for SNN's growth strategy 👉 https://www.zacks.com/commentary/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-body&ADID=SYND_STOCKTWITS_TWEET_2_2520779_BODY
0 ¡ Reply
ZacksResearch
ZacksResearch Jun. 20 at 2:43 PM
$SNN just made a strategic move that could shake up the orthopedic space 🦴 Teaming with Standard Health, it’s launching the UK’s first orthopedic ASC — a big play to boost surgical efficiency and fuel growth. See why this could be a game-changer for SNN 👉 https://www.zacks.com/stock/news/2520779/smith-nephew-stock-may-gain-from-strategic-deal-with-standard-health?cid=sm-stocktwits-2-2520779-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2520779_TEASER
0 ¡ Reply
JarvisFlow
JarvisFlow May. 1 at 7:57 PM
Canaccord Genuity has adjusted their stance on Smith & Nephew ( $SNN ), setting the rating to Hold with a target price of 27 → 28.
0 ¡ Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Mar. 26 at 7:33 PM
Smith & Nephew ($SNN) finds itself in the surgical sweet spot as the global market eyes $56.6B by 2029. With robotic systems like CORI and leadership in orthopedics, they're scrubbed in for growth. Now if they can just stop burning through cash faster than a cauterizing pen... https://www.prnewswire.com/news-releases/global-surgical-equipment-market-expected-to-reach-usd-56-6-billion-by-2029--302412416.html
0 ¡ Reply
JarvisFlow
JarvisFlow Mar. 17 at 3:40 PM
Canaccord Genuity updates rating for Smith & Nephew ( $SNN ) to Hold, target set at 27.
0 ¡ Reply
JarvisFlow
JarvisFlow Mar. 12 at 2:33 PM
UBS updates rating for Smith & Nephew ( $SNN ) to Neutral.
0 ¡ Reply
JarvisFlow
JarvisFlow Feb. 26 at 5:51 PM
Canaccord Genuity updates rating for Smith & Nephew ($SNN) to Hold, target set at 27.
0 ¡ Reply
30AMoney
30AMoney Feb. 25 at 9:27 PM
$SPY $SNN i hope some got in near $24/25, but its not too late she's a winner.
0 ¡ Reply
OpenOutcrier
OpenOutcrier Feb. 25 at 1:18 PM
$SNN (+4.0% pre) Smith & Nephew Shares Rise After Higher Profit, Revenue Offset China Headwinds - WSJ https://ooc.bz/l/57548
0 ¡ Reply
30AMoney
30AMoney Feb. 24 at 7:14 PM
$SNN held 24 & now in accumulation phase. Long
0 ¡ Reply
AnalystKrishna
AnalystKrishna Feb. 9 at 4:18 PM
$SNN at 24.67 support 1 at 23.9, Support 2 at 21.27, weak below 21.27 Target at 31
0 ¡ Reply
30AMoney
30AMoney Feb. 5 at 5:21 PM
$SNN she caught a bid! They sell the worlds best knee, hip & shoulder constructs. "the best survivorship figures of any total hip construct at 10 years."
0 ¡ Reply
VALMS
VALMS Jan. 24 at 7:34 PM
$SNN thinking of jumping in, any concerns about the debt to equity ratio?
0 ¡ Reply
711Coffee
711Coffee Jan. 17 at 6:59 PM
$SNN closed longs moved to $GME
0 ¡ Reply
Bio_Be_Dirty
Bio_Be_Dirty Jan. 17 at 5:50 PM
$SNN haven’t seen this spike in years
0 ¡ Reply
711Coffee
711Coffee Jan. 17 at 5:38 PM
$SNN $AMC $GME $BB
0 ¡ Reply
DosGatos
DosGatos Jan. 10 at 4:52 PM
$SNN What a dog!
0 ¡ Reply